Genevieve Boland, M.D., Ph.D.


Physician Investigator (Cl)
Surgery, Mass General Research Institute
Associate Professor of Surgery
Harvard Medical School
Associate Visiting Surgeon
Surgical Oncology, Massachusetts General Hospital
Director, Melanoma Surgery Program
Cancer Center, Massachusetts General Hospital
Surgical Director, Termeer Center for Targeted Therapies
Cancer Center, Massachusetts General Hospital
Director, Therapeutic Intralesional Program
Cancer Center, Massachusetts General Hospital
M.D.; Ph.D. Thomas Jefferson University 2006
cancer epigenetics; cancer immunotherapy; cell proliferation; checkpoint blockade; circulating biomarkers of melanoma; ctdna; exosomes; high risk melanoma; high risk skin cancer; intralesional therapy; melanoma; neoadjuvant therapy; neural crest; next-gen sequencing; proteomics; skin cancer; tumor microenvironment

Dr. Boland's research focuses on questions relating to melanoma genetics, biology, and immunology using genomic, transcriptomic, and proteomic approaches to profiling patient-derived samples.

Current Research Interests:

  1. Identification of circulating biomarkers of melanoma/cancer including circulating exosomes and/or ctDNA.
  2. Analysis of treatment-related effects on the tumor and microenvironment, including changes occurring during treatment with immunotherapy.
  3. Differential responses to immunotherapy and molecular/immunonological causes for heterogeneous responses to checkpoint blockade.
  4. The combined use of surgery and systemic therapy for treatment of high risk melanoma patients.
Research lab website Publications Clinical Profile
gmboland@partners.org
6177249913

Yawkey Center Outpatient Care
32 Fruit Street
Boston, MA 02114